Comparing two delivery methods for radiation beads to liver tumors
Part of Cancer clinical trials.
This trial compares two ways of delivering tiny radioactive beads (called Y-90 microspheres) directly to liver tumors. One method uses a standard catheter, while the other uses a special catheter that controls pressure to deliver the beads more precisely. The goal is to see which method works better for targeting tumors while sparing healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have multiple tumors that have spread to your liver.
- Your doctor has already decided that a treatment called radioembolization is right for you.
- You are 18 years of age or older.
- You are in generally good health (able to walk and take care of yourself).
- You have not had a prior embolization treatment in the part of the liver that will be treated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special catheter (TriNav) to deliver radiation directly to liver tumors. It aims to improve targeting and reduce side effects for people with liver cancer that cannot be surgically removed.
This trial tests a treatment that delivers tiny radioactive beads directly to liver tumors through a tube. It is for people with one or a few small liver tumors that cannot be removed with surgery or destroyed with heat or cold. The goal is to shrink or control the tumors with fewer side effects.
This trial tests a treatment called yttrium-90 radioembolization (tiny radioactive beads delivered to the liver) for people with liver cancer that has already been treated before. The goal is to see if it can help control the tumor when other treatments haven't been enough.
This trial tests two different ways to treat liver cancer that can't be removed with surgery. It compares stereotactic body radiation therapy (targeted high-dose radiation) with selective internal radiation therapy (tiny radioactive beads delivered through a blood vessel), both combined with immunotherapy (medicines that help your immune system fight cancer).
This trial tests a treatment that delivers tiny radioactive beads directly to liver tumors to shrink them, which may help patients become eligible for a liver transplant or surgery. It is for people with liver cancer that has not spread outside the liver.
This study tests a targeted radiation treatment called Y90 for liver tumors that are too large for standard approaches. It aims to see how well the treatment works for people with primary or secondary liver cancers that mainly affect the liver and have at least one tumor bigger than 5 cm.
Hear when a new Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.